Obstacles to the development of a safe and effective attenuated pre-erythrocytic stage malaria vaccine
- 1 May 2007
- journal article
- review article
- Published by Elsevier in Microbes and Infection
- Vol. 9 (6) , 761-766
- https://doi.org/10.1016/j.micinf.2007.02.006
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Calculation of Liver‐to‐Blood Inocula, Parasite Growth Rates, and Preerythrocytic Vaccine Efficacy, from Serial Quantitative Polymerase Chain Reaction Studies of Volunteers Challenged with Malaria SporozoitesThe Journal of Infectious Diseases, 2005
- Medicine: Knockout malaria vaccine?Nature, 2005
- Genetically modified Plasmodium parasites as a protective experimental malaria vaccineNature, 2004
- Incidence of severe Plasmodium falciparum malaria as a primary endpoint for vaccine efficacy trials in Bandiagara, MaliVaccine, 2004
- Plasma for fractionation: safety and quality issuesHaemophilia, 2004
- Progress in DNA‐based heterologous prime‐boost immunization strategies for malariaImmunological Reviews, 2004
- Protection of Humans against Malaria by Immunization with Radiation‐AttenuatedPlasmodium falciparumSporozoitesThe Journal of Infectious Diseases, 2002
- Complete Development of Mosquito Phases of the Malaria Parasite in VitroScience, 2002
- Efficacy of Recombinant Circumsporozoite Protein Vaccine Regimens against ExperimentalPlasmodium falciparumMalariaThe Journal of Infectious Diseases, 2001
- Protective Immunity produced by the Injection of X-irradiated Sporozoites of Plasmodium bergheiNature, 1967